UCP2 and Parkinson disease: This interpretation is backed up by the fact that UCP2 polymorphisms have not been reported in genome-wide association studies (GWAS) that investigated genetic factors underlying risk of Alzheimer’s disease (e.g. [37]) or Parkinson’s disease (e.g. [38]).